Role of Circulating Tumor DNA in Gastrointestinal Cancers: Update From Abstracts and Sessions at ASCO 2018
Background: The promising aspect of circulating tumor DNA (ctDNA) is its rapid turnaround and non-invasive nature. According to the American Society of Clinical Oncology (ASCO) and College of American Pathologists joint ctDNA review published in March 2018, there is not sufficient evidence to suppor...
Main Authors: | Faisal Shahjehan, Saivaishnavi Kamatham, Pashtoon Murtaza Kasi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.00358/full |
Similar Items
-
Circulating Tumor DNA-Based Detection of Microsatellite Instability and Response to Immunotherapy in Pancreatic Cancer
by: Saivaishnavi Kamatham, et al.
Published: (2020-02-01) -
State of the Art: ctDNA in Upper Gastrointestinal Malignancies
by: Ibone Labiano, et al.
Published: (2023-02-01) -
Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis
by: Estela Sánchez-Herrero, et al.
Published: (2022-07-01) -
Blood sample as a promising diagnostic tool in oncology - literature review
by: Dominik Drobek, et al.
Published: (2023-06-01) -
Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer—An Update
by: Joanna Kapeleris, et al.
Published: (2022-03-01)